National Philanthropic Trust’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$536K Buy
1,479
+107
+8% +$36.6K 0.01% 296
2026
Q1
$483K Buy
1,372
+6
+0.4% +$2.14K 0.01% 279
2025
Q4
$447K Buy
1,366
+7
+0.5% +$2.22K ﹤0.01% 283
2025
Q3
$384K Buy
1,359
+285
+27% +$82.7K ﹤0.01% 246
2025
Q2
$300K Buy
1,074
+14
+1% +$3.97K ﹤0.01% 246
2025
Q1
$330K Buy
1,060
+7
+0.7% +$2.07K 0.01% 219
2024
Q4
$274K Buy
1,053
+7
+0.7% +$2.08K ﹤0.01% 237
2024
Q3
$337K Buy
1,046
+6
+0.6% +$1.96K 0.01% 210
2024
Q2
$325K Sell
1,040
-191
-16% -$56.1K 0.01% 221
2024
Q1
$350K Sell
1,231
-26
-2% -$7.61K 0.01% 219
2023
Q4
$362K Buy
+1,257
New +$342K 0.01% 230

Other funds holding AMGN

National Philanthropic Trust's AMGN Position: Q2 2026 in Review

National Philanthropic Trust increased its Amgen (AMGN) stake by 7.8% in Q2 2026, buying an estimated $36.6K and bringing the position to 1,479 shares worth $536K. The position accounts for 0.01% of the portfolio, ranked #296.

National Philanthropic Trust first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 3,029 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • National Philanthropic Trust held 1,479 shares of Amgen worth $536K as of Q2 2026.
  • National Philanthropic Trust bought 107 Amgen shares in Q2 2026, an estimated $36.6K.
  • Amgen made up 0.01% of National Philanthropic Trust's portfolio in Q2 2026, its #296 holding.
  • National Philanthropic Trust first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • 3,029 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on National Philanthropic Trust's 13F filing for Q2 2026, filed 14 Aug 2026.